Rigel Pharma (RIGL) Tops Q4 EPS by 2c, Tops on Revenue
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $35.75 +0.06%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $34.1 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
- Carnival shares drop despite earnings beat on weak guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
